Cosmos Health Stock Rises on Libytec Manufacturing Deal
Cosmos Health Stock Surges on PathMuscle Manufacturing Deal Following the announcement of a manufacturing deal for PathMuscle, a pharmaceutical product that combines a muscle relaxant and pain reliever, Cosmos Health Inc. (NASDAQ:COSM) shares increased 3.7% on Monday. Details of the PathMuscle Manufacturing Agreement Libytec Pharmaceutical S.A., which has exclusive distribution rights in Greece, will get … Read more